Inventor
RAFAELI OMER
IL38 patents
⚠️ This page may combine multiple inventors who share the name “RAFAELI OMER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AZURA OPHTHALMICS LTD
19 patentsUS10688122B2Jun 23, 2020
Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
AZURA OPHTHALMICS LTD18 citations94
US10588915B2Mar 17, 2020
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD19 citations94
US10772899B2Sep 15, 2020
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD8 citations92
US12048707B2Jul 30, 2024
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD3 citations85
US11633410B2Apr 25, 2023
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD6 citations85
US11324775B2May 10, 2022
Compositions and methods for the treatment of contact lens discomfort
AZURA OPHTHALMICS LTD8 citations83
US11040062B2Jun 22, 2021
Selenium disulfide compositions for use in treating meibomian gland dysfunction
AZURA OPHTHALMICS LTD8 citations83
US11013749B2May 25, 2021
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD7 citations83
US12011457B2Jun 18, 2024
Selenium disulfide compositions for use in treating meibomian gland dysfunction
AZURA OPHTHALMICS LTD3 citations73
US11517586B2Dec 6, 2022
Instructions for composition and sensitivity
AZURA OPHTHALMICS LTD2 citations71
US10875845B2Dec 29, 2020
Compounds and methods for the treatment of ocular disorders
AZURA OPHTHALMICS LTD4 citations70
US12447162B2Oct 21, 2025
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD0 citations62
US12427158B2Sep 30, 2025
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD0 citations62
US11484516B2Nov 1, 2022
Agents for increasing meibomian gland lipid secretion
AZURA OPHTHALMICS LTD0 citations62
US12458661B2Nov 4, 2025
Selenium disulfide compositions for use in treating meibomian gland dysfunction
AZURA OPHTHALMICS LTD0 citations61
US12083147B2Sep 10, 2024
Compositions and methods for the treatment of contact lens discomfort
AZURA OPHTHALMICS LTD1 citations60
US11643429B2May 9, 2023
Compounds and methods for the treatment of ocular disorders
AZURA OPHTHALMICS LTD0 citations59
US11634411B2Apr 25, 2023
Compounds and methods for the treatment of ocular disorders
AZURA OPHTHALMICS LTD1 citations59
US11459351B1Oct 4, 2022
Compounds and methods for the treatment of ocular disorders
AZURA OPHTHALMICS LTD1 citations58
NOTAL VISION LTD
9 patentsUS10595722B1Mar 24, 2020
Automatic optical path adjustment in home OCT
NOTAL VISION LTD13 citations85
US10653314B2May 19, 2020
Methods and systems for alignment of ophthalmic imaging devices
NOTAL VISION LTD8 citations83
US11389061B2Jul 19, 2022
Methods and systems for alignment of ophthalmic imaging devices
NOTAL VISION LTD2 citations72
US11058299B2Jul 13, 2021
Retinal imaging device and related methods
NOTAL VISION LTD3 citations69
US11986241B2May 21, 2024
Automatic optical path adjustment in home OCT
NOTAL VISION LTD0 citations62
US11723536B2Aug 15, 2023
Methods and systems for alignment of ophthalmic imaging devices
NOTAL VISION LTD0 citations62
US11464408B2Oct 11, 2022
Automatic optical path adjustment in home OCT
NOTAL VISION LTD0 citations62
US12137977B2Nov 12, 2024
Retinal imaging device and related methods
NOTAL VISION LTD0 citations58
US12458284B2Nov 4, 2025
OCT guided therapy
NOTAL VISION LTD0 citations43